<p>Transamerica Financial Advisors Inc. 在最近向证券交易委员会提交的文件中表示，在第三季度减少了对礼来公司的股份，减少幅度为 18.9%。该机构投资者在季度内出售了 1,760 股后，持有 7,535 股该公司的股票。在最近的报告期结束时，Transamerica Financial Advisors Inc. 在礼来公司的持股价值为 6,675,000 美元。</p>
<p>获取 <strong>礼来公司</strong> 的提醒：</p>
<ul>
<li>礼来、辉瑞和阿斯利康：2025 年值得关注的疫苗制造商</li>
</ul>
<p>其他对冲基金和机构投资者最近也调整了对该公司的持股。Virtu Financial LLC 在第一季度购买了价值 2,138,000 美元的礼来公司新股份。Chesley Taft &amp; Associates LLC 在第二季度将其在礼来公司的持股增加了 5.4%。Chesley Taft &amp; Associates LLC 目前持有 22,553 股该公司的股票，价值 20,419,000 美元，此前在上个季度又增持了 1,163 股。OMNI 360 Wealth Inc. 在第二季度购买了价值约 239,000 美元的礼来公司新股份。Long Run Wealth Advisors LLC 在第二季度购买了价值约 209,000 美元的礼来公司新股份。最后，Essex Financial Services Inc. 在第二季度将其在礼来公司的持股增加了 5.8%。Essex Financial Services Inc. 目前持有 28,183 股该公司的股票，价值 25,517,000 美元，此前在上个季度又增持了 1,556 股。目前 82.53% 的股票由机构投资者持有。</p>
<h2>分析师评级调整</h2>
<p>几位股票分析师最近对 LLY 股票发表了评论。美国银行在 10 月 31 日的研究报告中将礼来公司的目标价从 1,150.00 美元下调至 1,100.00 美元，并对该股票给予 “买入” 评级。Truist Financial 在 10 月 10 日的研究报告中将礼来公司的目标价从 1,000.00 美元上调至 1,033.00 美元，并给予该公司 “买入” 评级。Cantor Fitzgerald 在 9 月 16 日的报告中重申了 “增持” 评级，并对礼来公司的股票设定了 885.00 美元的目标价。巴克莱在 10 月 31 日的报告中将礼来公司的目标价从 1,025.00 美元下调至 975.00 美元，并对该股票给予 “增持” 评级。最后，古根海姆在 8 月 16 日的研究报告中将礼来公司的目标价从 884.00 美元上调至 1,030.00 美元，并给予该股票 “买入” 评级。四位投资分析师对该股票给予了持有评级，十七位分析师给予了买入评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 1,007.94 美元。</p>
<ul>
<li>3 只在第三季度业绩优异且 2024 年展望强劲的顶级股票</li>
</ul>
<p><strong>查看我们对礼来公司的最新股票分析</strong></p>
<h2>内部交易活动</h2>
<p>在相关消息中，首席会计官 Donald A. Zakrowski 在 11 月 8 日（星期五）出售了 900 股该股票。股票以 803.38 美元的平均价格出售，总价值为 723,042.00 美元。出售完成后，首席会计官现在直接持有 5,480 股该公司的股票，价值约为 4,402,522.40 美元。这代表其持股减少了 14.11%。该交易已在 SEC 的法律文件中披露，可以通过此链接访问。内部人士持有该公司 0.13% 的股票。</p>
<h2>礼来公司股票表现</h2>
<ul>
<li>MarketBeat 周评 – 11/4 - 11/8</li>
</ul>
<p>在周二的午盘交易中，NYSE:LLY 上涨 29.69 美元，达到 784.69 美元。该公司的股票交易量为 1,682,225 股，而其平均交易量为 3,197,027 股。该公司的流动比率为 1.27，速动比率为 0.97，债务与股本比率为 2.03。该股票的市值为 7449.2 亿美元，市盈率为 81.62，市盈增长比率为 2.83，贝塔值为 0.43。该公司的 50 日移动平均价格为 861.63 美元，200 日移动平均价格为 870.20 美元。礼来公司的 12 个月低点为 561.65 美元，12 个月高点为 972.53 美元。</p>
<p>礼来公司（NYSE:LLY - 获取免费报告）最近于 10 月 30 日（星期三）发布了季度财报。该公司报告季度每股收益为 1.18 美元，低于市场共识预期的 1.52 美元，差额为 0.34 美元。该公司季度收入为 114.4 亿美元，而市场共识预期为 120.9 亿美元。礼来公司的净利润率为 20.48%，股本回报率为 71.08%。与去年同期相比，礼来公司的季度收入增长了 20.4%。在去年同期，该公司每股收益为 0.10 美元。分析师平均预测礼来公司本财年将发布 13.2 美元的每股收益。</p>
<h2>礼来公司股息公告</h2>
<p>该公司最近还宣布了季度股息，将于 12 月 10 日（星期二）支付。11 月 15 日（星期五）的股东将获得每股 1.30 美元的股息。这代表每年 5.20 美元的股息和 0.66% 的股息收益率。除息日期为 11 月 15 日（星期五）。礼来公司的股息支付比率目前为 56.22%。</p>
<h2>关于礼来公司</h2>
<p>（免费报告）</p>
<p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素 lispro、胰岛素 lispro 原料、胰岛素 lispro 混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；以及 Zepbound 用于肥胖。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，胜过礼来公司</li>
<li>内部人士卖出股票的解释：这能否影响你的投资选择？</li>
<li>3 只股票授权了 10 亿美元的股票回购以提升价值</li>
<li>股票市场升级：它们是什么？</li>
<li>Pure Storage 的 GenAI Pods 和 AI 趋势可能会引发复苏</li>
<li>如何知道一只股票是否支付股息以及何时支付</li>
<li>Seaboard Corporation 是否是投资者的感恩节盛宴？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<p>→ 免费下载我们的特斯拉电子书（来自 DTI）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDI3OA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDI3OA"/></p>
<h2>你现在应该投资 1000 美元在礼来公司吗？</h2>
<p>在考虑礼来公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而礼来公司并不在名单上。</p>
<p>虽然礼来公司目前在分析师中有 “适度买入” 的评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

礼来

<p>Transamerica Financial Advisors Inc. 在第三季度减少了对礼来的持股，降幅为 18.9%，目前持有 7,535 股，价值 67.5 万美元。其他机构投资者也调整了他们的持股。分析师对该股票的评级不一，目前的平均评级为 “适度买入”，目标价格为 1,007.94 美元。礼来的股票表现显示市值为 920 亿美元，市盈率为 81.62。该公司报告每股收益为 1.18 美元，低于预期 34 美分</p>

<p>Transamerica Financial Advisors Inc. lessened its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 18.9% in the third quarter, according to its most recent filing with the Securities &amp; Exchange Commission. The institutional investor owned 7,535 shares of the company's stock after selling 1,760 shares during the quarter. Transamerica Financial Advisors Inc.'s holdings in Eli Lilly and Company were worth $6,675,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Transamerica Financial Advisors Inc. 在最近向证券交易委员会提交的文件中表示，在第三季度减少了对礼来公司的股份，减少幅度为 18.9%。该机构投资者在季度内出售了 1,760 股后，持有 7,535 股该公司的股票。在最近的报告期结束时，Transamerica Financial Advisors Inc. 在礼来公司的持股价值为 6,675,000 美元。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的提醒：</p>
</div><ul>
<li>Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch</li>
</ul>
<div class="lb-trans"><ul>
<li>礼来、辉瑞和阿斯利康：2025 年值得关注的疫苗制造商</li>
</ul>
</div><p>Other hedge funds and other institutional investors have also recently modified their holdings of the company. Virtu Financial LLC bought a new stake in Eli Lilly and Company during the first quarter valued at $2,138,000. Chesley Taft &amp; Associates LLC raised its holdings in shares of Eli Lilly and Company by 5.4% in the 2nd quarter. Chesley Taft &amp; Associates LLC now owns 22,553 shares of the company's stock valued at $20,419,000 after acquiring an additional 1,163 shares in the last quarter. OMNI 360 Wealth Inc. bought a new stake in shares of Eli Lilly and Company during the 2nd quarter valued at about $239,000. Long Run Wealth Advisors LLC purchased a new position in shares of Eli Lilly and Company during the second quarter worth about $209,000. Finally, Essex Financial Services Inc. increased its position in shares of Eli Lilly and Company by 5.8% in the second quarter. Essex Financial Services Inc. now owns 28,183 shares of the company's stock worth $25,517,000 after purchasing an additional 1,556 shares during the last quarter. 82.53% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他对冲基金和机构投资者最近也调整了对该公司的持股。Virtu Financial LLC 在第一季度购买了价值 2,138,000 美元的礼来公司新股份。Chesley Taft &amp; Associates LLC 在第二季度将其在礼来公司的持股增加了 5.4%。Chesley Taft &amp; Associates LLC 目前持有 22,553 股该公司的股票，价值 20,419,000 美元，此前在上个季度又增持了 1,163 股。OMNI 360 Wealth Inc. 在第二季度购买了价值约 239,000 美元的礼来公司新股份。Long Run Wealth Advisors LLC 在第二季度购买了价值约 209,000 美元的礼来公司新股份。最后，Essex Financial Services Inc. 在第二季度将其在礼来公司的持股增加了 5.8%。Essex Financial Services Inc. 目前持有 28,183 股该公司的股票，价值 25,517,000 美元，此前在上个季度又增持了 1,556 股。目前 82.53% 的股票由机构投资者持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级调整</h2>
</div><p>Several equities analysts have recently commented on LLY shares. Bank of America reduced their price objective on Eli Lilly and Company from $1,150.00 to $1,100.00 and set a &#34;buy&#34; rating on the stock in a research report on Thursday, October 31st. Truist Financial increased their price target on shares of Eli Lilly and Company from $1,000.00 to $1,033.00 and gave the company a &#34;buy&#34; rating in a research report on Thursday, October 10th. Cantor Fitzgerald restated an &#34;overweight&#34; rating and issued a $885.00 price objective on shares of Eli Lilly and Company in a report on Monday, September 16th. Barclays reduced their target price on shares of Eli Lilly and Company from $1,025.00 to $975.00 and set an &#34;overweight&#34; rating on the stock in a report on Thursday, October 31st. Finally, Guggenheim boosted their price target on shares of Eli Lilly and Company from $884.00 to $1,030.00 and gave the stock a &#34;buy&#34; rating in a research note on Friday, August 16th. Four investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $1,007.94.</p>
<div class="lb-trans"><p>几位股票分析师最近对 LLY 股票发表了评论。美国银行在 10 月 31 日的研究报告中将礼来公司的目标价从 1,150.00 美元下调至 1,100.00 美元，并对该股票给予 “买入” 评级。Truist Financial 在 10 月 10 日的研究报告中将礼来公司的目标价从 1,000.00 美元上调至 1,033.00 美元，并给予该公司 “买入” 评级。Cantor Fitzgerald 在 9 月 16 日的报告中重申了 “增持” 评级，并对礼来公司的股票设定了 885.00 美元的目标价。巴克莱在 10 月 31 日的报告中将礼来公司的目标价从 1,025.00 美元下调至 975.00 美元，并对该股票给予 “增持” 评级。最后，古根海姆在 8 月 16 日的研究报告中将礼来公司的目标价从 884.00 美元上调至 1,030.00 美元，并给予该股票 “买入” 评级。四位投资分析师对该股票给予了持有评级，十七位分析师给予了买入评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 1,007.94 美元。</p>
</div><ul>
<li>3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只在第三季度业绩优异且 2024 年展望强劲的顶级股票</li>
</ul>
</div><p><strong>Check Out Our Latest Stock Analysis on Eli Lilly and Company</strong></p>
<div class="lb-trans"><p><strong>查看我们对礼来公司的最新股票分析</strong></p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部交易活动</h2>
</div><p>In related news, CAO Donald A. Zakrowski sold 900 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $803.38, for a total value of $723,042.00. Following the completion of the sale, the chief accounting officer now directly owns 5,480 shares of the company's stock, valued at approximately $4,402,522.40. This represents a 14.11 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.13% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，首席会计官 Donald A. Zakrowski 在 11 月 8 日（星期五）出售了 900 股该股票。股票以 803.38 美元的平均价格出售，总价值为 723,042.00 美元。出售完成后，首席会计官现在直接持有 5,480 股该公司的股票，价值约为 4,402,522.40 美元。这代表其持股减少了 14.11%。该交易已在 SEC 的法律文件中披露，可以通过此链接访问。内部人士持有该公司 0.13% 的股票。</p>
</div><h2>Eli Lilly and Company Stock Performance</h2>
<div class="lb-trans"><h2>礼来公司股票表现</h2>
</div><ul>
<li>MarketBeat Week in Review – 11/4 - 11/8</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周评 – 11/4 - 11/8</li>
</ul>
</div><p>NYSE:LLY traded up $29.69 during mid-day trading on Tuesday, reaching $784.69. The company's stock had a trading volume of 1,682,225 shares, compared to its average volume of 3,197,027. The company has a current ratio of 1.27, a quick ratio of 0.97 and a debt-to-equity ratio of 2.03. The stock has a market cap of $744.92 billion, a P/E ratio of 81.62, a PEG ratio of 2.83 and a beta of 0.43. The firm's fifty day moving average price is $861.63 and its two-hundred day moving average price is $870.20. Eli Lilly and Company has a 12-month low of $561.65 and a 12-month high of $972.53.</p>
<div class="lb-trans"><p>在周二的午盘交易中，NYSE:LLY 上涨 29.69 美元，达到 784.69 美元。该公司的股票交易量为 1,682,225 股，而其平均交易量为 3,197,027 股。该公司的流动比率为 1.27，速动比率为 0.97，债务与股本比率为 2.03。该股票的市值为 7449.2 亿美元，市盈率为 81.62，市盈增长比率为 2.83，贝塔值为 0.43。该公司的 50 日移动平均价格为 861.63 美元，200 日移动平均价格为 870.20 美元。礼来公司的 12 个月低点为 561.65 美元，12 个月高点为 972.53 美元。</p>
</div><p>Eli Lilly and Company (NYSE:LLY - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.18 earnings per share for the quarter, missing the consensus estimate of $1.52 by ($0.34). The firm had revenue of $11.44 billion for the quarter, compared to the consensus estimate of $12.09 billion. Eli Lilly and Company had a net margin of 20.48% and a return on equity of 71.08%. Eli Lilly and Company's quarterly revenue was up 20.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.10 earnings per share. On average, equities analysts forecast that Eli Lilly and Company will post 13.2 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>礼来公司（NYSE:LLY - 获取免费报告）最近于 10 月 30 日（星期三）发布了季度财报。该公司报告季度每股收益为 1.18 美元，低于市场共识预期的 1.52 美元，差额为 0.34 美元。该公司季度收入为 114.4 亿美元，而市场共识预期为 120.9 亿美元。礼来公司的净利润率为 20.48%，股本回报率为 71.08%。与去年同期相比，礼来公司的季度收入增长了 20.4%。在去年同期，该公司每股收益为 0.10 美元。分析师平均预测礼来公司本财年将发布 13.2 美元的每股收益。</p>
</div><h2>Eli Lilly and Company Dividend Announcement</h2>
<div class="lb-trans"><h2>礼来公司股息公告</h2>
</div><p>The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 10th. Stockholders of record on Friday, November 15th will be paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 0.66%. The ex-dividend date is Friday, November 15th. Eli Lilly and Company's dividend payout ratio is presently 56.22%.</p>
<div class="lb-trans"><p>该公司最近还宣布了季度股息，将于 12 月 10 日（星期二）支付。11 月 15 日（星期五）的股东将获得每股 1.30 美元的股息。这代表每年 5.20 美元的股息和 0.66% 的股息收益率。除息日期为 11 月 15 日（星期五）。礼来公司的股息支付比率目前为 56.22%。</p>
</div><h2>About Eli Lilly and Company</h2>
<div class="lb-trans"><h2>关于礼来公司</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.</p>
<div class="lb-trans"><p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素 lispro、胰岛素 lispro 原料、胰岛素 lispro 混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；以及 Zepbound 用于肥胖。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Eli Lilly and Company</li>
<li>Insider Selling Explained: Can it Inform Your Investing Choices?</li>
<li>3 Stocks That Authorized $1 Billion Stock Buybacks to Boost Value</li>
<li>Stock Market Upgrades: What Are They?</li>
<li>Pure Storage's GenAI Pods and AI Trends Could Spark Recovery</li>
<li>How to Know if a Stock Pays Dividends and When They Are Paid Out</li>
<li>Is Seaboard Corporation a Thanksgiving Feast for Investors?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过礼来公司</li>
<li>内部人士卖出股票的解释：这能否影响你的投资选择？</li>
<li>3 只股票授权了 10 亿美元的股票回购以提升价值</li>
<li>股票市场升级：它们是什么？</li>
<li>Pure Storage 的 GenAI Pods 和 AI 趋势可能会引发复苏</li>
<li>如何知道一只股票是否支付股息以及何时支付</li>
<li>Seaboard Corporation 是否是投资者的感恩节盛宴？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=LLY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><p>→ Download Our Tesla Ebook For Free (From DTI)(Ad)</p>
<div class="lb-trans"><p>→ 免费下载我们的特斯拉电子书（来自 DTI）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDI3OA" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10278&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Eli Lilly and Company right now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑礼来公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然礼来公司目前在分析师中有 “适度买入” 的评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Transamerica Financial Advisors Inc. 减少了在礼来公司（NYSE:LLY）的股份